+Dalethyne prevents nosocomial infection without antibiotics

Tinuku ~ Airlangga University students bring +Dalethyne as a nosocomial infection solution without antibiotics. Kayapan Satya Dharsha designing an active compound is expected to be a breakthrough to overcome the nosocomial infections that have become the biggest challenge of global health services.

Tinuku +Dalethyne prevents nosocomial infection without antibiotics

The 21st Meeting of the Indonesian Plastic Surgery Specialist Society in Yogyakarta conveys a discussion of +Dalethyne active substances that can be prevented nosocomial infection before, during and after medical intervention.

+Dalethyne is the exclusive active substance used in Dermazone MedCare products and is believed to kill germs that cause nosocomial infections are MRSA, ESBL, KPC and Pseudomonas aeruginosa.

Substance designed by Kayapan Satya Dharsha, an Airlangga University Student in Surabaya, is a breakthrough for surgical wound therapy without the consumption of antibiotics, but has the same advantages as antibiotics to control bacteria.

Dharsha and team worked more than a decade to create a machine to produce active substances. Dalet is four in Hebrew to symbolize the four main forces as an antiseptic, preventing antimicrobial resistance, eliminating scarring and accelerating skin proliferation.

"Currently we are continuing to research to maximize the use of +Dalethyne to prevent nosocomial infections and other major health care issues," Dharsha said in a press release on Friday, May 12, 2017.

The active substance has been tested in the UK, Japan and Malaysia. +Dalethyne has exclusively been used in PT Dermozone Pratama Indonesia product line for wound care and skin health. Throughout 2016, +Dalethyne at 50% concentration kills germs that cause nosocomial infections.

The ointment containing +Dalethyne is applied to the local wound immediately removes the odor and removes the pus in the surgical wound of squamous cell carcinoma in the penis at stage 4 without any antibiotic consumption.

WHO data noted that 10% of the world's patients with nosocomial infections are suffering in Southeast Asia. The problem is increasingly complicated the more rampant cases of microbial resistance causes 700,000 deaths each year.

A study predicts microbial resistance causes 10 million deaths annually by 2050 and spends US$10 trillion in prevention funds each year. Superbug has been found in the Intensive Care Unit (ICU) and 64% of cases of infections in the bloodstream and surgical wound.